Lépjen offline állapotba az Player FM alkalmazással!
New Alzheimer's Drug Approval Expands Treatment Options — and Creates Coverage Questions
Manage episode 429611005 series 3305949
Health Affairs' Jeff Byers welcomes Senior Editor Leslie Erdelack to the program to discuss FDA's recent approval of an Alzheimer's treatment drug, Lilly’s Kisunla, how private insurers and Medicare may cover the drug, and the emerging new class of drugs surrounding Alzheimer's treatment.
We announced the winner for our You're A Health Policy Wonk If... contest this week!
Check out our Request For Abstracts page for the April 2025 theme issue focusing on Food, Nutrition, and Health.
Related Articles:
- Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment by Peter Loftus and Joseph Walker (Wall Street Journal)
- Press Release: Lilly's Kisunla Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
194 epizódok
Manage episode 429611005 series 3305949
Health Affairs' Jeff Byers welcomes Senior Editor Leslie Erdelack to the program to discuss FDA's recent approval of an Alzheimer's treatment drug, Lilly’s Kisunla, how private insurers and Medicare may cover the drug, and the emerging new class of drugs surrounding Alzheimer's treatment.
We announced the winner for our You're A Health Policy Wonk If... contest this week!
Check out our Request For Abstracts page for the April 2025 theme issue focusing on Food, Nutrition, and Health.
Related Articles:
- Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment by Peter Loftus and Joseph Walker (Wall Street Journal)
- Press Release: Lilly's Kisunla Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
194 epizódok
Minden epizód
×Üdvözlünk a Player FM-nél!
A Player FM lejátszó az internetet böngészi a kiváló minőségű podcastok után, hogy ön élvezhesse azokat. Ez a legjobb podcast-alkalmazás, Androidon, iPhone-on és a weben is működik. Jelentkezzen be az feliratkozások szinkronizálásához az eszközök között.